| Description | Retifanlimab, an anti-programmed cell death protein 1 (anti-PD-1) monoclonal antibody (mAb), is utilized in the research of gastroesophageal adenocarcinoma (GEA) [1]. |
| molecular weight | N/A |
| CAS | 2079108-44-2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years |